Filing Details
- Accession Number:
- 0001209191-14-038851
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-06-03 21:23:32
- Reporting Period:
- 2014-05-29
- Filing Date:
- 2014-06-03
- Accepted Time:
- 2014-06-03 21:23:32
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1087432 | Intermune Inc | ITMN | Pharmaceutical Preparations (2834) | 943296648 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1304113 | William Kenneth Andrew Powell | 3280 Bayshore Blvd Brisbane CA 94005 | Evp, Gc & Secretary | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-04-30 | 1,277 | $12.31 | 32,027 | No | 5 | J | Direct | |
| Common Stock | Disposition | 2014-05-29 | 500 | $39.56 | 31,527 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-05-30 | 500 | $39.32 | 31,027 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 5 | J | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted stock units | Acquisiton | 2014-05-29 | 3,500 | $0.00 | 3,500 | $0.00 |
| Common Stock | Performance stock units | Acquisiton | 2014-05-29 | 5,250 | $0.00 | 5,250 | $0.00 |
| Common Stock | Stock options (right to buy) | Acquisiton | 2014-05-29 | 17,500 | $0.00 | 17,500 | $40.26 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 3,500 | No | 4 | A | Direct | ||
| 5,250 | No | 4 | A | Direct | ||
| 17,500 | 2021-05-28 | No | 4 | A | Direct |
Footnotes
- Reflects acquisition of shares in a transaction exempt from Section 16(b) of the Securities Exchange Act under InterMune, Inc. Employee Stock Purchase Plan.
- Each restricted stock unit represents a contingent right to receive one share of InterMune, Inc. common stock.
- Twenty-five percent (25%) of the total number of restricted stock units shall become vested and releasable on each yearly anniversary of the grant date. Shares of common stock of the company issued upon completion of vesting of each installment of the restricted stock units will be delivered to the reporting person following the completion of vesting of the corresponding installment.
- Each performance stock unit represents a contingent right to receive one share of InterMune, Inc. common stock.
- Performance stock units are subject to vest upon pre-specified performance criteria, as determined by the Board of Directors.
- Twenty-five percent (25%) of the total number of shares subject to the stock option vest and become exercisable on the first anniversary of the grant date. The remainder of the option shares vests and becomes exercisable cumulatively in equal monthly installments over the following thirty-six (36) months.
Billionaire Hedge Funds
